arrow
C

Cameron Green

monash university
H指数:37
被引数:8,477

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Simvastatin in Critically Ill Patients with Covid-19

辛伐他汀在重症新型冠状病毒肺炎患者中的应用

2023-12-2123
OAAI
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
2023-11-1423
OA
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对新型冠状病毒肺炎住院患者无器官支持天数的影响随机临床试验

2023-04-1135
OA
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2023-01-0379
OA
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial
2022-04-0590
OA
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

新型冠状病毒肺炎恢复期血浆治疗与死亡率的关系: 一项随机临床试验的协作系统评价和荟萃分析

2021-11-2050
OAAI
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

恢复期血浆对重症新型冠状病毒肺炎患者无器官支持天数的影响: 一项随机临床试验

2021-11-02148
OA
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study

全球重症监护病房的终末期实践的变化 (Ethicus-2): 一项前瞻性观察研究

2021-10-0183
PREAI
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
2021-08-26591
OAAI
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
2021-08-26569
OAAI
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021-07-1264
OAAI
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
2021-04-221.3K
OAAI
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
2020-10-061.6K
OAAI
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
2020-10-06447
OAAI
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study Rationale and Design
2020-07-01267
OAAI